Neuigkeiten aus dem New Yorker Krebs-Zentrum.
April 2006 Lately@mskcc.org 
http://www.mskcc.org/Lately@MSKCC
Welcome to Lately@MSKCC,
Memorial Sloan-Kettering Cancer Center’s monthly
enewsletter.
INCLUDED IN THIS ISSUE
============================================================
* MRI Screening for Women at High Risk of Breast Cancer
* Yankees Universe Fund Unveiled
* Pediatric Patient Story – Perry Zimmerman
* An Interview with Kathleen M. Foley
* Protein Regulates Quiescent Blood Stem Cells That Are
  Linked to Enhanced Recovery from Radiation and
  Chemotherapy
* Investigators Show How Key Growth Factor Influences Immune
  System
* The Latest in Colorectal Cancer: Screening, Diagnosis, and
  Treatment
============================================================
************************************************************
MAKE A GIFT – http://www.mskcc.org/MakeAGift
************************************************************
MRI Screening for Women at High Risk of Breast Cancer
  A woman with a family history of breast cancer often lives
  under a cloud of anxious uncertainty, wondering if the
  disease that affected her mother, sister, or other
  first-degree relative may strike her as well. Fortunately,
  a number of studies suggest that women at high risk for
  developing breast cancer may benefit from magnetic
  resonance imaging (MRI) screening, providing these women
  with a new option they can use to help address their
  concerns.
http://www.mskcc.org/65116
WHAT’S NEW AT MSKCC.ORG
———————–
Yankees Universe Fund Unveiled
  The New York Yankees and Memorial Sloan-Kettering Cancer
  Center have joined together to support the Center’s
  programs in pediatric patient care, research, and
  education by creating the New York Yankees Universe fund.
http://www.mskcc.org/63978
Pediatric Patient Story – Perry Zimmerman
  To meet Perry Zimmerman, you would think you’re meeting a
  typical, albeit cute and precocious, five-year-old. What
  you wouldn’t know was that Perry has faced and conquered
  more life-threatening obstacles in her short life than
  most people could even begin to imagine. Born with a rare
  cancer of the eye known as retinoblastoma that spread to
  her brain, Perry successfully fought through five cycles
  of chemotherapy and one stem cell transplant at Memorial
  Sloan-Kettering to overcome the cancer. After such an
  arduous journey made by such a little girl, it is
  understandable that her parents, Larry and Anne Zimmerman,
  think of her as their little miracle.
http://www.mskcc.org/63160
An Interview with Kathleen M. Foley
  Memorial Sloan-Kettering neurologist Kathleen M. Foley
  focuses on the assessment and treatment of pain in cancer
  patients, as well as on developing policies for pain and
  palliative care worldwide. She is the incumbent of The
  Society of Memorial Sloan-Kettering Cancer Center Chair
  and former Chief of the Pain and Palliative Care Service.
  Dr. Foley chairs the International Association for Hospice
  and Palliative Care and is a member of the Institute of
  Medicine of the National Academies.
http://www.mskcc.org/63672
RESEARCH AT MEMORIAL SLOAN-KETTERING
————————————
Protein Regulates Quiescent Blood Stem Cells That Are Linked
to Enhanced Recovery from Radiation and Chemotherapy
  Memorial Sloan-Kettering scientists and colleagues have
  uncovered new information about what orchestrates the
  complex balance between blood stem cells and mature blood
  cells, a relationship that is often disrupted in leukemia.
  The results, published in the March issue of Cancer Cell,
  will lead to a better understanding of the behavior of
  leukemic cells and may have vital clinical applications
  for patients recovering from chemotherapy, radiation
  therapy, or bone marrow transplantation.
http://www.mskcc.org/63981
Investigators Show How Key Growth Factor Influences Immune
System
  Memorial Sloan-Kettering investigators Joan Massaguý and
  Dori A. Thomas have published a paper showing how the
  protein called transforming growth factor-beta (TGF-ý)
  allows tumor cells to escape killing by the immune system.
  TGF-ý has been a well-studied cellular protein in cancer
  research because it can act as either an inhibitor or a
  promoter of cell growth.
http://www.mskcc.org/63671
CANCER INFORMATION & SCREENINGS
——————————-
The Latest in Colorectal Cancer: Screening, Diagnosis, and
Treatment
  On Thursday May 4th, join Memorial Sloan-Kettering
  physicians — Sidney J. Winawer, MD, Attending Physician,
  Gastroenterology and Nutrition Service; Martin R. Weiser,
  MD, Assistant Attending Surgeon, Colorectal Service; and
  Leonard B. Saltz, MD, Attending Physician — for an
  overview of colorectal cancer.
http://www.mskcc.org/63211
************************************************************